Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Positive Outlook on WD40 with 313 Price Target

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Tech-banking-finance
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

On March 5, 2024, analyst Linda Bolton Weiser from DA Davidson reiterated her positive outlook on WD-40 (NASDAQ: WDFC), maintaining a Buy rating and a price target of $313. Amid discussions surrounding the company’s growth targets, DA Davidson has raised questions about the feasibility of WD-40 Co’s ambitious sales projections. Despite concerns about negative free cash flow, WD-40 has shown strong stock performance, with a 12% increase in price since the last quarterly report and a 44.5% surge over the year, outperforming the S&P 500. Looking ahead, Linda Bolton Weiser remains optimistic about WD-40’s potential, highlighting a Strong Buy or Buy rating from top analysts and forecasting an EPS of $5.88 for the upcoming year.

WD-40 Company (WDFC) Stock Price Drops Slightly on March 5, 2024, But Remains Bullish

On March 5, 2024, WD-40 Company (WDFC) experienced a slight drop in its stock price, closing at $266.09. This represents a decrease of $2.20, or 0.82%, from the previous market close. Despite this decline, WDFC is still trading near the top of its 52-week range and above its 200-day simple moving average. This suggests that investors have been bullish on the stock in recent months. Additionally, the fact that WDFC is trading above its 200-day simple moving average is another positive sign for the stock. Despite the slight drop in price on March 5, WDFC has remained relatively stable in after-hours trading, suggesting that investors may not be overly concerned about the price decline and are still confident in the company’s long-term prospects. Overall, WDFC’s performance on March 5, 2024, reflects a stock that is still in a strong position, trading near its highs and showing signs of bullish momentum. Investors will likely continue to monitor the stock closely to see if it can maintain its upward trajectory in the coming days and weeks.

WD-40 Company Reports Mixed Financial Performance for Past Year and Q1 2024

On March 5, 2024, WD-40 Company (WDFC) reported its financial performance for the past year and the first quarter of the current fiscal year. According to data from CNN Money, the company’s total revenue for the past year was $537.25 million, which represents a 3.55% increase compared to the previous year. However, the total revenue for the first quarter of the current fiscal year was $140.42 million, which remained flat compared to the previous quarter.

In terms of net income, WD-40 Company reported a net income of $65.72 million for the past year, which remained flat compared to the previous year. However, the net income for the first quarter of the current fiscal year was $17.42 million, representing a 5.49% increase compared to the previous quarter.

Earnings per share (EPS) for WD-40 Company were reported at $4.83 for the past year, which remained flat compared to the previous year. However, the EPS for the first quarter of the current fiscal year was $1.28, reflecting a 5.59% increase compared to the previous quarter.

Overall, WD-40 Company’s financial performance on March 5, 2024, showed a mixed result. While the total revenue and net income remained relatively stable, there was a slight increase in EPS for the first quarter of the current fiscal year. Investors and analysts will be closely monitoring the company’s performance in the coming quarters.

Tags: WDFC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Myers Industries Stock Surges 13 After Strong Q4 Results and FY24 Guidance

IT-Healthcare

Title Launch of KARDIA3 Trial Evaluating Zilebesiran for Uncontrolled Hypertension

Biopharmaceutical

Exciting Progress for BI1206 in NonHodgkins Lymphoma Treatment

Recommended

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

6 months ago
Dynatrace Holdings LLC Stock

Dynatrace Holdings LLC Stock: Strong Q1 Performance Beats Expectations

8 months ago
MP Materials Stock

MP Materials: Record Production Amid Financial Headwinds

4 months ago
Omv Stock

OMV Faces Critical Juncture as Qatar Threatens European Gas Supplies

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Trending

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

by Jackson Burston
March 25, 2026
0

Fair Isaac Corporation, the company behind the ubiquitous FICO credit score, is facing a dual-pronged assault that...

Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem
  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com